CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing’s Sarcoma
NCT 05440786 Intervention / Treatment Drug: Abemaciclib Drug: Irinotecan Drug: Temozolomide Inclusion Criteria Diagnosis of…
Read more arrow_forwardNCT 05440786 Intervention / Treatment Drug: Abemaciclib Drug: Irinotecan Drug: Temozolomide Inclusion Criteria Diagnosis of…
Read more arrow_forwardNCT 05523947 Brief Summary This first-in-human study will be counducted to evaluate…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05756907 Brief Summary This is a Phase 1b/2a, open-label, adaptive-design…
Read more arrow_forwardInside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.